Literature DB >> 7632155

Axillary lymphadenectomy for breast cancer without axillary drainage.

S S Jeffrey1, W H Goodson, D M Ikeda, R L Birdwell, M S Bogetz.   

Abstract

OBJECTIVE: To evaluate axillary lymph node dissection done without closed drainage in conjunction with breast conservation cancer surgery.
DESIGN: Prospective clinical study.
SETTING: Two university hospitals. PATIENTS: Eighty-one women undergoing wide local excision of breast cancer with simultaneous or subsequent axillary lymph node dissection.
INTERVENTIONS: No axillary drain was placed following axillary lymphadenectomy. MAIN OUTCOME MEASURES: The development and resorption of axillary seroma fluid as measured by clinical aspiration and serial sonographic examination.
RESULTS: Thirty-four (42%) of the 81 women required axillary seroma aspiration even though axillary fluid was present in 92% (22/24) of those studied sonographically. The seromas accumulated over the first 2 weeks following axillary dissection and resorbed over the next 2 weeks, as assessed by both clinical and sonographic examination. The complication rate was 2% (2/81). The surgery was performed safely on an outpatient or short-stay basis in 99% (80/81) of patients. All patients except one were discharged within 23 hours of surgery, and 56 patients were discharged directly after anesthesia.
CONCLUSION: Axillary lymph node dissection done in conjunction with breast conservation surgery can be performed in an ambulatory or short-stay setting without axillary drainage. Postoperative seromas will resolve within 1 month, and fewer than half will require aspiration. Lymphadenectomy without drainage reduces morbidity and allows the patient greater personal comfort.

Entities:  

Mesh:

Year:  1995        PMID: 7632155     DOI: 10.1001/archsurg.1995.01430080111018

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial.

Authors:  J Bonnema; A M van Wersch; A N van Geel; J F Pruyn; P I Schmitz; M A Paul; T Wiggers
Journal:  BMJ       Date:  1998-04-25

2.  Argon beam coagulation as an adjunct in breast-conserving surgery.

Authors:  P Ridings; C Bailey; T E Bucknall
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

3.  Axillary lymphadenectomy for breast cancer in elderly patients and fibrin glue.

Authors:  Giovanni Docimo; Paolo Limongelli; Giovanni Conzo; Simona Gili; Alfonso Bosco; Antonia Rizzuto; Vincenzo Amoroso; Salvatore Marsico; Nicola Leone; Antonio Esposito; Chiara Vitiello; Landino Fei; Domenico Parmeggiani; Ludovico Docimo
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

4.  The Use of TissuGlu® Surgical Adhesive for Mastectomy With or Without Lymphonodectomy.

Authors:  Ralf Ohlinger; Leonie Gieron; Rico Rutkowski; Thomas Kohlmann; Marek Zygmunt; Julia Unger
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

Review 5.  Wound drainage after axillary dissection for carcinoma of the breast.

Authors:  David R Thomson; Hazim Sadideen; Dominic Furniss
Journal:  Cochrane Database Syst Rev       Date:  2013-10-20

6.  Capsulectomy Can Successfully Treat Chronic Encapsulated Breast Seroma: A Case Report.

Authors:  Kjersti Fosheim; Sophie Bojesen; Hannah Troestrup; Anne-Vibeke Laenkholm
Journal:  Cureus       Date:  2022-01-27

7.  Seroma formation after breast cancer surgery: what we have learned in the last two decades.

Authors:  Vivek Srivastava; Somprakas Basu; Vijay Kumar Shukla
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

8.  Efficacy of fibrin glue on seroma formation after breast surgery.

Authors:  Mahmood Reza Miri Bonjar; Hemmat Maghsoudi; Roya Samnia; Parviz Saleh; Farhang Parsafar
Journal:  Int J Breast Cancer       Date:  2012-09-12

9.  Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial.

Authors:  Lobna Ouldamer; Julia Bonastre; Solène Brunet-Houdard; Gilles Body; Bruno Giraudeau; Agnès Caille
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.